应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
GILD 吉利德科学
盘后交易 02-03 19:18:19 EST
143.28
+0.39
+0.27%
盘后
144.35
+1.07
+0.75%
19:16 EST
最高
145.94
最低
142.03
成交量
684.02万
今开
142.16
昨收
142.89
日振幅
2.74%
总市值
1,778亿
流通市值
1,774亿
总股本
12.41亿
成交额
9.88亿
换手率
0.55%
流通股本
12.38亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Wolfe上调吉利德科学目标价至155美元
格隆汇 · 01-30
Wolfe上调吉利德科学目标价至155美元
美国联邦医保将新增15种药物价格谈判
环球市场播报 · 01-29
美国联邦医保将新增15种药物价格谈判
Truist上调吉利德科学目标价至145美元
中金财经 · 01-28
Truist上调吉利德科学目标价至145美元
医保药品价格谈判第三轮选定药物公布:安诺罗易利达、必克特维、保妥适、保妥适美容针、辛齐亚、科森提斯入选
美股速递 · 01-28
医保药品价格谈判第三轮选定药物公布:安诺罗易利达、必克特维、保妥适、保妥适美容针、辛齐亚、科森提斯入选
BMO Capital上调吉利德科学目标价至150美元
格隆汇 · 01-27
BMO Capital上调吉利德科学目标价至150美元
《新英格兰医学杂志》发布三期临床研究Ascent-04/Keynote-D19结果:Trodelvy®联合Keytruda®有望成为PD-L1阳性转移性三阴性乳腺癌一线治疗新标准
美股速递 · 01-22
《新英格兰医学杂志》发布三期临床研究Ascent-04/Keynote-D19结果:Trodelvy®联合Keytruda®有望成为PD-L1阳性转移性三阴性乳腺癌一线治疗新标准
吉利德科学盘中异动 下午盘股价大涨3.01%报127.88美元
市场透视 · 01-22
吉利德科学盘中异动 下午盘股价大涨3.01%报127.88美元
吉利德科学高管披露:已向FDA提交Anito-Cel申请,预计本季度获受理函,目标2026年下半年上市
美股速递 · 01-13
吉利德科学高管披露:已向FDA提交Anito-Cel申请,预计本季度获受理函,目标2026年下半年上市
吉利德高管透露:Lenacapavir去年底首次在撒哈拉以南非洲国家完成交付 与美国上市同年实现
美股速递 · 01-13
吉利德高管透露:Lenacapavir去年底首次在撒哈拉以南非洲国家完成交付 与美国上市同年实现
瑞银上调吉利德科学目标价至145美元
格隆汇 · 01-08
瑞银上调吉利德科学目标价至145美元
Onconano Medicine与吉利德科学达成协议扩展选项:后者可通过指定新靶点将合作金额提升至3亿美元
美股速递 · 01-06
Onconano Medicine与吉利德科学达成协议扩展选项:后者可通过指定新靶点将合作金额提升至3亿美元
美股异动 | 与吉利德科学(GILD.US)达成出售实验性抗癌资产协议 Repare Therapeutics(RPTX.US)盘前一度大涨约20%
智通财经网 · 2025-12-24
美股异动 | 与吉利德科学(GILD.US)达成出售实验性抗癌资产协议 Repare Therapeutics(RPTX.US)盘前一度大涨约20%
吉利德科学行使许可选项,以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目
美股速递 · 2025-12-22
吉利德科学行使许可选项,以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
智通财经 · 2025-12-20
默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
美股速递 · 2025-12-20
美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易
公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员
美股速递 · 2025-12-20
公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员
多家制造商同意向美国战略储备捐赠活性药物成分
美股速递 · 2025-12-20
多家制造商同意向美国战略储备捐赠活性药物成分
III期ARTISTRY-2研究达主要终点,吉利德新型HIV二联疗法展现潜力
药事纵横 · 2025-12-18
III期ARTISTRY-2研究达主要终点,吉利德新型HIV二联疗法展现潜力
吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点
美股速递 · 2025-12-15
吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点
吉利德科学 - 中期分析显示,Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期
美股速递 · 2025-12-12
吉利德科学 - 中期分析显示,Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期
加载更多
公司概况
公司名称:
吉利德科学
所属市场:
NASDAQ
上市日期:
--
主营业务:
吉利德科学公司于1987年6月22日在特拉华州成立,是一家以研究为基础的生物制药公司,致力于发现,开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病,炎性和纤维化疾病以及肿瘤学。
发行价格:
--
{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":143.28,"timestamp":1770152400000,"preClose":142.89,"halted":0,"volume":6840182,"hourTrading":{"tag":"盘后","latestPrice":144.35,"preClose":143.28,"latestTime":"19:16 EST","volume":426205,"amount":61068685.39785001,"timestamp":1770164166967,"change":1.07,"changeRate":0.007468,"amplitude":0.010888},"delay":0,"changeRate":0.0027293722443838954,"floatShares":1238162880,"shares":1240679623,"eps":6.422841,"marketStatus":"盘后交易","change":0.39,"latestTime":"02-03 19:18:19 EST","open":142.16,"high":145.94,"low":142.03,"amount":988143772.8148401,"amplitude":0.027364,"askPrice":145.45,"askSize":5,"bidPrice":143,"bidSize":20,"shortable":3,"etf":0,"ttmEps":6.422841,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1770166800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":142.89,"dividendRate":0.021915,"preHourTrading":{"tag":"盘前","latestPrice":142.91,"preClose":142.89,"latestTime":"09:29 EST","volume":2959,"amount":421756.83363,"timestamp":1770128999999,"change":0.02,"changeRate":0.00014,"amplitude":0.008118},"postHourTrading":{"tag":"盘后","latestPrice":144.35,"preClose":143.28,"latestTime":"19:16 EST","volume":426205,"amount":61068685.39785001,"timestamp":1770164166967,"change":1.07,"changeRate":0.007468,"amplitude":0.010888},"volumeRatio":0.825306,"impliedVol":0.3479,"impliedVolPercentile":0.6534},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2607015389","title":"Wolfe上调吉利德科学目标价至155美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2607015389","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607015389?lang=zh_cn&edition=full","pubTime":"2026-01-30 17:40","pubTimestamp":1769766002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1674673428.USD","LU1674673691.USD","IE00B19Z3581.USD","LU0882574055.USD","LU1839511570.USD","LU1778281490.HKD","LU0289739699.SGD","LU0320765992.SGD","BK4139","IE00BZ1G4Q59.USD","LU1571399168.USD","BK4566","IE00BKVL7J92.USD","LU1430594728.SGD","BK4568","IE00B7SZLL34.SGD","LU0823416689.USD","LU0234570918.USD","IE00B19Z3B42.SGD","LU0114720955.EUR","GILD","SG9999015945.SGD","BK4550","IE0002270589.USD","LU1066053197.SGD","LU1066051498.USD","LU2089984988.USD","BK4578","IE00B3T34201.USD","IE00BSNM7G36.USD","LU2468319806.SGD","SG9999015978.USD","LU2324357040.USD","BK4532","LU2087621335.USD","LU0109394709.USD","BK4583","LU1585245621.USD","BK4585","LU0058720904.USD","SG9999015952.SGD","SG9999015986.USD","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2607743095","title":"美国联邦医保将新增15种药物价格谈判","url":"https://stock-news.laohu8.com/highlight/detail?id=2607743095","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607743095?lang=zh_cn&edition=full","pubTime":"2026-01-29 00:19","pubTimestamp":1769617140,"startTime":"0","endTime":"0","summary":"美国联邦医疗保险和医疗补助服务中心(Centers for Medicare and Medicaid Services,CMS)在其价格谈判计划中新增15种药物(包括Trulicity和Biktarvy),可能影响礼来(LLY)和吉利德科学(GILD),新价格将于2028年起生效。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:张俊 SF065","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-01-29/doc-inhiwtem8714142.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU1430594728.SGD","SG9999014898.SGD","BK4568","BK4599","LU0385154629.USD","LU1064131342.USD","BK4139","LU0289739699.SGD","LU2471134952.CNY","LU1988902786.USD","SG9999013999.USD","IE00B7SZLL34.SGD","LU1839511570.USD","LU2746668974.SGD","LU0417517546.SGD","IE00BK4W5L77.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","LU2168563687.JPY","LU2168564222.USD","LU0466842654.USD","SG9999015986.USD","IE00BKDWB100.SGD","SG9999001176.SGD","SG9999014906.USD","LU2237443978.SGD","LU2111349929.HKD","LU2491050071.SGD","IE00BJT1NW94.SGD","BK4516","SG9999015945.SGD","LU0354030511.USD","LU2023251221.USD","LU1868837136.USD","LU0114720955.EUR","LU0471298694.HKD","LU0820561818.USD","LU2237443382.USD","LU2361045086.USD","BK4566","LU2028103732.USD","LU0882574055.USD","LU1868836591.USD","LU0823434740.USD","LU0689472784.USD","LU1267930730.SGD","LU0323591593.USD","SGXZ51526630.SGD","LU2237443622.USD","IE00BFSS8Q28.SGD","LU2468319806.SGD","LU0683600562.USD","LU2236285917.USD","LU2237443895.HKD","IE0004445239.USD","LU2552382058.USD","SGXZ99366536.SGD","SGXZ57979304.SGD","IE00B19Z3581.USD","IE00B775H168.HKD","LU0786609619.USD","LU1069344957.HKD","LU0210536198.USD","LU1585245621.USD","LU2491049909.HKD","BK4533","LU1983299246.USD","BK4578","LU2168564495.EUR","BK4550","SGXZ31699556.SGD","LU0109394709.USD","SG9999018865.SGD","LU0234570918.USD","LU1712237335.SGD","LU2087625088.SGD","IE0005OL40V9.USD","IE00BFSS7M15.SGD","LU2237443549.SGD","IE00B1BXHZ80.USD","LU1814569148.SGD","IE00B4JS1V06.HKD","LU1868837300.USD","LU0256863902.USD","LU0353189680.USD","IE00BJJMRX11.SGD","LU0471298777.SGD","LU0353189763.USD","LU2462157665.USD","LU2264538146.SGD","LU0234572021.USD","LU1061106388.HKD","LU1127390331.HKD","LU2089284900.SGD","LU2271345857.HKD","LU0058720904.USD","LU2106854487.HKD","LU1551013342.USD","IE00B3T34201.USD","LU1571399168.USD","IE0002270589.USD","LU1548497426.USD","SG9999015952.SGD","BK4588","LU2089283258.USD","LU0432979614.USD","IE00BN29S564.USD","LU1868836757.USD","LU0158827781.USD","IE00B7KXQ091.USD","SG9999014914.USD","LU1720051017.SGD","IE00BJJMRY28.SGD","LU1674673691.USD","LU0316494557.USD","LU0943347566.SGD","BK4007","LU1023059063.AUD","SG9999017495.SGD","BK4585","LU0097036916.USD","LU0354030438.USD","LU2023250504.SGD","SG9999018857.SGD","LU0006306889.USD","LU0640476718.USD","LU2456880835.USD","LU1057294990.SGD","IE00BKVL7J92.USD","LU0820561909.HKD","LU1974910355.USD","LU2361044949.HKD","LU0320765992.SGD","LU0225283273.USD","LU1066051498.USD","IE00B4R5TH58.HKD","LU2896262040.SGD","LU2750360997.AUD","LU0456855351.SGD","LU0320765059.SGD","IE0009355771.USD","LU1623119135.USD","LU2357305700.SGD","IE00B1XK9C88.USD","LU1323610961.USD","LU0203202063.USD","LU1093756168.USD","LU1989771016.USD","LU0203201768.USD","LU2265009873.SGD","BK4532","LU2746668461.USD","LU0198837287.USD","BK4581","LU0238689110.USD","LU2087621335.USD","LU1093756325.SGD","SGXZ81514606.USD","BK4583","LU0106261372.USD","LU0061475181.USD","LU2168564149.EUR","LU0823434583.USD","SG9999015978.USD","IE00B19Z3B42.SGD","LU0094547139.USD","LU1778281490.HKD","LU2211815571.USD","LU2602419157.SGD","IE00B2B36J28.USD","LU2471134796.USD","LU1035775433.USD","LU1674673428.USD","LU2324357040.USD","LU2417539215.USD","IE00BJLML261.HKD","LU0158827948.USD","LU0889565916.HKD","LU0708995401.HKD","LU0823416689.USD","BK4534","LU1720051108.HKD","IE00BSNM7G36.USD","LU2461242641.AUD","LU0266013472.USD","SG9999014880.SGD","LU2552382132.HKD","LU0122379950.USD","LU1232071149.USD","IE00BJJMRZ35.SGD","LU2237443465.HKD","GB00BDT5M118.USD","GILD","LU1804176565.USD","LU0079474960.USD","LU2750360641.GBP","LU2089984988.USD","LU2360106947.USD","LU0882574139.USD","LU2491050154.USD","LU0672654240.SGD","LU1868836914.USD","LU1917777945.USD","LLY","IE0004445015.USD","IE00BKPKM429.USD","LU1066053197.SGD","LU2063271972.USD","LU2471134523.USD","LU2552382215.SGD","LU1291159041.SGD","LU1366192091.USD","IE0002141913.USD","LU0109391861.USD","LU2112291526.USD","LU2168564065.EUR","SINA","LU0096364046.USD","LU1280957306.USD","LU0256863811.USD","IE00BK4W5M84.HKD","LU2361044865.SGD","LU2471134879.HKD","SG9999001176.USD","IE00BWXC8680.SGD","IE00BZ1G4Q59.USD","LU2108987350.USD","LU1551013425.SGD","LU0787776722.HKD"],"gpt_icon":0},{"id":"2606999527","title":"Truist上调吉利德科学目标价至145美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606999527","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606999527?lang=zh_cn&edition=full","pubTime":"2026-01-28 16:57","pubTimestamp":1769590622,"startTime":"0","endTime":"0","summary":"Truist Securities将吉利德科学的目标价从140美元上调至145美元,维持“买入”评级。(格隆汇)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260128/31979579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["GILD"],"gpt_icon":0},{"id":"1184786153","title":"医保药品价格谈判第三轮选定药物公布:安诺罗易利达、必克特维、保妥适、保妥适美容针、辛齐亚、科森提斯入选","url":"https://stock-news.laohu8.com/highlight/detail?id=1184786153","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184786153?lang=zh_cn&edition=full","pubTime":"2026-01-28 05:40","pubTimestamp":1769550053,"startTime":"0","endTime":"0","summary":"美国医疗保险和医疗补助服务中心近日公布了第三轮药品价格谈判的选定药物名单。此次入围的药品包括用于慢性阻塞性肺病的安诺罗易利达、治疗艾滋病的必克特维、以及广泛应用于医疗与美容领域的保妥适和保妥适美容针。此外,自身免疫疾病治疗药物辛齐亚与科森提斯也成功入选。下一步,CMS将与企业就药品价格进行直接协商,最终谈判价格将于2024年公布。此举被视为美国控制医疗成本上涨的关键措施之一。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4139","BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU1839511570.USD","LU0289739699.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1674673428.USD","LU0889565916.HKD","IE0002270589.USD","IE00B3T34201.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4583","SG9999015978.USD","LU1778281490.HKD","LU1066051498.USD","LU0823416689.USD","BK4532","ALVO","LU0882574055.USD","SG9999015952.SGD","SG9999015986.USD","BK4585","LU0058720904.USD","LU1430594728.SGD","LU2087621335.USD","LU1066053197.SGD","GILD","IE00B19Z3581.USD","LU2324357040.USD","BK4588","LU1571399168.USD","LU2468319806.SGD","BK4550","LU2089984988.USD","SG9999015945.SGD","BK4578"],"gpt_icon":0},{"id":"2606206531","title":"BMO Capital上调吉利德科学目标价至150美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606206531","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606206531?lang=zh_cn&edition=full","pubTime":"2026-01-27 15:43","pubTimestamp":1769499816,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["SG9999015952.SGD","LU0889565916.HKD","LU0320765992.SGD","LU1839511570.USD","LU0109394709.USD","LU1430594728.SGD","BK4532","IE00BZ1G4Q59.USD","BK4578","IE00BKVL7J92.USD","LU1674673691.USD","LU1585245621.USD","LU2089984988.USD","BMO","SG9999015945.SGD","LU0289739699.SGD","IE00B7SZLL34.SGD","SG9999015978.USD","LU1778281490.HKD","LU1571399168.USD","VTA","IE00BSNM7G36.USD","BK4568","IE0002270589.USD","IE00B19Z3581.USD","LU0234570918.USD","BK4585","LU1066051498.USD","LU1066053197.SGD","LU2087621335.USD","BK4566","BK4139","LU0058720904.USD","BK4550","BK4583","GILD","IE00B3T34201.USD","LU2324357040.USD","LU2468319806.SGD","LU0114720955.EUR","LU0823416689.USD","IE00B19Z3B42.SGD","LU0882574055.USD","SG9999015986.USD","BK4207","BK4588","LU1674673428.USD"],"gpt_icon":0},{"id":"1175285034","title":"《新英格兰医学杂志》发布三期临床研究Ascent-04/Keynote-D19结果:Trodelvy®联合Keytruda®有望成为PD-L1阳性转移性三阴性乳腺癌一线治疗新标准","url":"https://stock-news.laohu8.com/highlight/detail?id=1175285034","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175285034?lang=zh_cn&edition=full","pubTime":"2026-01-22 06:02","pubTimestamp":1769032941,"startTime":"0","endTime":"0","summary":"《新英格兰医学杂志》最新刊发的三期临床试验Ascent-04/Keynote-D19研究数据显示,Trodelvy®与Keytruda®联合疗法展现出显著疗效。这一突破性进展为PD-L1阳性转移性三阴性乳腺癌患者的一线治疗提供了新选择。\n研究结果证实,联合用药方案在客观缓解率和无进展生存期等关键指标上均优于现有标准疗法。该疗法有望重塑临床实践格局,为晚期三阴性乳腺癌治疗领域注入新动能。\n此次发布的数据进一步验证了免疫联合靶向治疗的协同作用机制。随着后续研究推进,这种创新组合或将成为该类患者群体的一线标准治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3581.USD","LU1674673691.USD","BK4583","BK4568","LU1839511570.USD","IE0002270589.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU1585245621.USD","BK4588","LU0320765992.SGD","IE00B7SZLL34.SGD","SG9999015945.SGD","SG9999015952.SGD","LU2089984988.USD","IE00B19Z3B42.SGD","LU1430594728.SGD","SG9999015978.USD","LU0289739699.SGD","LU0882574055.USD","BK4585","LU0823416689.USD","LU2087621335.USD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4566","LU0234570918.USD","LU0109394709.USD","LU1674673428.USD","LU1066053197.SGD","LU0114720955.EUR","LU1571399168.USD","BK4550","LU1066051498.USD","IE00BSNM7G36.USD","LU2468319806.SGD","BK4532","BK4139","BK4578","LU0889565916.HKD","GILD","LU2324357040.USD","SG9999015986.USD"],"gpt_icon":0},{"id":"2605048457","title":"吉利德科学盘中异动 下午盘股价大涨3.01%报127.88美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605048457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605048457?lang=zh_cn&edition=full","pubTime":"2026-01-22 02:20","pubTimestamp":1769019631,"startTime":"0","endTime":"0","summary":"北京时间2026年01月22日02时20分,吉利德科学股票出现波动,股价急速上涨3.01%。截至发稿,该股报127.88美元/股,成交量241.731万股,换手率0.19%,振幅4.16%。吉利德科学股票所在的制药行业中,整体涨幅为2.50%。吉利德科学公司简介:吉利德科学开发和销售治疗和预防危及生命的传染病的疗法,其投资组合的核心集中在艾滋病毒和乙型肝炎和丙型肝炎。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122022031953dc6f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260122022031953dc6f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4532","IE00BZ1G4Q59.USD","LU2087621335.USD","LU1839511570.USD","SG9999015952.SGD","BK4585","IE00B7SZLL34.SGD","LU1066051498.USD","GILD","LU1066053197.SGD","LU0823416689.USD","IE00B19Z3581.USD","LU0289739699.SGD","LU2089984988.USD","LU1778281490.HKD","BK4566","LU1674673691.USD","BK4578","LU0058720904.USD","LU0320765992.SGD","BK4568","LU1571399168.USD","SG9999015945.SGD","LU2324357040.USD","SG9999015978.USD","BK4139","LU0109394709.USD","LU0234570918.USD","SG9999015986.USD","LU1430594728.SGD","BK4550","IE0002270589.USD","LU2468319806.SGD","IE00B19Z3B42.SGD","LU0882574055.USD","LU1585245621.USD","IE00BKVL7J92.USD","IE00B3T34201.USD","LU0114720955.EUR","LU0889565916.HKD","LU1674673428.USD","BK4588","IE00BSNM7G36.USD","BK4583"],"gpt_icon":0},{"id":"1189517059","title":"吉利德科学高管披露:已向FDA提交Anito-Cel申请,预计本季度获受理函,目标2026年下半年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1189517059","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1189517059?lang=zh_cn&edition=full","pubTime":"2026-01-13 03:31","pubTimestamp":1768246278,"startTime":"0","endTime":"0","summary":"吉利德科学高管近日透露,公司已正式向美国食品药品监督管理局(FDA)提交嵌合抗原受体T细胞疗法Anito-Cel的上市申请。目前正等待监管机构发出受理确认函,预计将于本季度内收到相关通知。若审批进展顺利,该疗法计划于2026年下半年正式推向市场。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","BK4566","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU0889565916.HKD","LU0234570918.USD","LU0320765992.SGD","LU1585245621.USD","BK4578","BK4588","LU0109394709.USD","LU1674673428.USD","LU1571399168.USD","BK4583","BK4139","LU0823416689.USD","LU1066051498.USD","LU0114720955.EUR","IE00BSNM7G36.USD","LU0882574055.USD","LU0058720904.USD","IE00BZ1G4Q59.USD","LU1674673691.USD","IE00B19Z3581.USD","LU2089984988.USD","BK4550","SG9999015945.SGD","SG9999015978.USD","LU1066053197.SGD","BK4585","IE00B19Z3B42.SGD","GILD","SG9999015986.USD","LU2468319806.SGD","BK4568","LU1778281490.HKD","LU2324357040.USD","BK4532","LU1839511570.USD","LU2087621335.USD","LU1430594728.SGD","IE0002270589.USD","IE00BKVL7J92.USD","SG9999015952.SGD"],"gpt_icon":0},{"id":"1166649682","title":"吉利德高管透露:Lenacapavir去年底首次在撒哈拉以南非洲国家完成交付 与美国上市同年实现","url":"https://stock-news.laohu8.com/highlight/detail?id=1166649682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166649682?lang=zh_cn&edition=full","pubTime":"2026-01-13 03:28","pubTimestamp":1768246101,"startTime":"0","endTime":"0","summary":"吉利德科学公司高管近日披露,其创新HIV治疗药物Lenacapavir于去年年底首次在撒哈拉以南非洲地区完成交付。这一里程碑事件的发生时间,恰逢该药物同期在美国市场正式推出之年。此次突破性进展标志着抗艾滋病药物可及性的重要跨越,凸显了创新医疗方案向全球高危区域同步推进的战略意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0058720904.USD","LU0889565916.HKD","IE0002270589.USD","SG9999015978.USD","LU1430594728.SGD","IE00BKVL7J92.USD","BK4550","LU1674673691.USD","BK4578","IE00B3T34201.USD","LU1839511570.USD","LU0882574055.USD","GILD","SG9999015945.SGD","BK4566","LU0320765992.SGD","BK4568","BK4139","LU1571399168.USD","LU1674673428.USD","LU1778281490.HKD","LU2324357040.USD","IE00B19Z3581.USD","LU0234570918.USD","SG9999015986.USD","LU0109394709.USD","LU0114720955.EUR","LU1585245621.USD","LU2468319806.SGD","BK4583","BK4585","IE00B7SZLL34.SGD","LU0823416689.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU2089984988.USD","SG9999015952.SGD","BK4588","LU2087621335.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU0289739699.SGD","LU1066051498.USD"],"gpt_icon":0},{"id":"2601435481","title":"瑞银上调吉利德科学目标价至145美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601435481","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601435481?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:47","pubTimestamp":1767862058,"startTime":"0","endTime":"0","summary":null,"market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4566","LU1585245621.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4139","BK4568","IE00BKVL7J92.USD","LU1674673691.USD","LU1839511570.USD","LU0289739699.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1674673428.USD","LU0889565916.HKD","IE0002270589.USD","IE00B3T34201.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4583","SG9999015978.USD","LU1778281490.HKD","LU1066051498.USD","LU0823416689.USD","BK4532","LU0882574055.USD","SG9999015952.SGD","SG9999015986.USD","BK4585","LU0058720904.USD","LU1430594728.SGD","LU2087621335.USD","LU1066053197.SGD","GILD","IE00B19Z3581.USD","LU2324357040.USD","BK4588","LU1571399168.USD","LU2468319806.SGD","BK4550","LU2089984988.USD","SG9999015945.SGD","BK4578"],"gpt_icon":0},{"id":"1126031375","title":"Onconano Medicine与吉利德科学达成协议扩展选项:后者可通过指定新靶点将合作金额提升至3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126031375","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126031375?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:12","pubTimestamp":1767701537,"startTime":"0","endTime":"0","summary":"Onconano Medicine近日宣布,其合作伙伴吉利德科学拥有扩展现有合作协议的选项权。根据协议条款,吉利德科学可通过为Onconano Medicine的on-Board技术平台指定额外靶点来触发协议扩展,此举将使Onconano Medicine获得最高达3亿美元的潜在收益。\n该选项机制为双方合作提供了灵活性,既体现了吉利德科学对on-Board技术平台的持续认可,也展现出Onconano Medicine在肿瘤纳米医学领域的创新价值。若吉利德科学行使该选项权,Onconano Medicine将获得包括里程碑付款在内的综合收益,进一步强化其研发资金储备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","BK4568","BK4139","LU2089984988.USD","IE0002270589.USD","BK4532","IE00B19Z3B42.SGD","LU1066051498.USD","LU2087621335.USD","SG9999015978.USD","LU1674673691.USD","BK4585","LU1066053197.SGD","LU0823416689.USD","LU2324357040.USD","BK4588","LU0882574055.USD","LU0114720955.EUR","BK4550","BK4566","LU0058720904.USD","LU1778281490.HKD","BK4578","GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU1571399168.USD","SG9999015945.SGD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0234570918.USD","IE00B19Z3581.USD","LU1430594728.SGD","SG9999015952.SGD","SG9999015986.USD","LU0289739699.SGD","LU0320765992.SGD","LU2468319806.SGD","LU1674673428.USD","IE00BSNM7G36.USD","BK4583","LU0109394709.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2593047013","title":"美股异动 | 与吉利德科学(GILD.US)达成出售实验性抗癌资产协议 Repare Therapeutics(RPTX.US)盘前一度大涨约20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593047013","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593047013?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:19","pubTimestamp":1766585945,"startTime":"0","endTime":"0","summary":"该公司已与吉利德科学达成资产购买协议,收购其实验性抗癌疗法RP-3467,交易总价值最高可达3000万美元","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"09853388b565e5412a3d944672ba7d17","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0289739699.SGD","BK4566","IE00B19Z3581.USD","BK4568","IE00BKVL7J92.USD","BK4539","IE00BZ1G4Q59.USD","IE00B3T34201.USD","LU0234570918.USD","LU0882574055.USD","BK4007","BK4139","LU0114720955.EUR","LU1571399168.USD","LU1674673428.USD","LU1674673691.USD","LU1430594728.SGD","BK4583","LU0058720904.USD","LU1066053197.SGD","SG9999015945.SGD","LU0889565916.HKD","LU2468319806.SGD","GILD","SG9999015952.SGD","IE00B7SZLL34.SGD","BK4588","IE0002270589.USD","IE00BSNM7G36.USD","RPTX","LU0320765992.SGD","BK4550","LU1066051498.USD","LU1778281490.HKD","SG9999015986.USD","LENZ","LU1839511570.USD","LU2089984988.USD","BK4585","SG9999015978.USD","LU0109394709.USD","BK4532","LU2324357040.USD","LU2087621335.USD","LU1585245621.USD","IE00B19Z3B42.SGD","LU0823416689.USD","BK4578"],"gpt_icon":0},{"id":"1177566900","title":"吉利德科学行使许可选项,以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566900","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177566900?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:03","pubTimestamp":1766408625,"startTime":"0","endTime":"0","summary":"吉利德科学行使许可选项,以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1066053197.SGD","BK4566","LU1839511570.USD","IE00BZ1G4Q59.USD","SG9999015945.SGD","IE00B7SZLL34.SGD","IE00B19Z3581.USD","ASMB","LU0058720904.USD","LU2468319806.SGD","BK4585","LU1430594728.SGD","LU0320765992.SGD","LU1674673691.USD","IE00B19Z3B42.SGD","LU0823416689.USD","BK4139","SG9999015952.SGD","BK4583","SG9999015986.USD","LU0114720955.EUR","LU2324357040.USD","BK4578","BK4568","LU0289739699.SGD","LU2089984988.USD","SG9999015978.USD","LU1674673428.USD","BK4532","IE00BSNM7G36.USD","GILD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1585245621.USD","LU0109394709.USD","IE00B3T34201.USD","LU0234570918.USD","LU2087621335.USD","LU0882574055.USD","BK4550","LU1066051498.USD","LU1571399168.USD","LU1778281490.HKD","BK4588","IE0002270589.USD"],"gpt_icon":0},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际,多家美国及欧洲大型制药企业近日与白宫达成协议,同意自愿下调在美销售的药品价格,以换取关税豁免和政策支持。在此次协议中,最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示,今年7月他致信要求降价的17家大型制药企业中,已有14家同意大幅下调药价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1430594728.SGD","GSK","LU0980610538.SGD","LU2242646821.SGD","LU0289739699.SGD","SG9999013999.USD","SG9999014567.USD","SG9999002224.SGD","04332","SG9999015341.SGD","LU1670711123.USD","LU1037948897.HKD","IE00BFTCPJ56.SGD","JNJ","SG9999001176.SGD","IE00BN8TJ469.HKD","LU1670710661.SGD","LU1116320901.HKD","LU2133065610.SGD","IE00BJT1NW94.SGD","BK4516","LU0965508806.USD","LU2125154935.USD","LU1989772923.USD","SG9999014542.SGD","LU0203347892.USD","LU1670710588.SGD","LU1868837136.USD","LU0114720955.EUR","LU1934455863.HKD","BMY","LU2361045086.USD","LU0882574055.USD","LU0985320562.USD","AZN","LU0868494617.USD","IE000M9KFDE8.USD","LU1868836591.USD","LU1032466523.USD","LU0237698245.USD","LU2468319806.SGD","LU0130517989.USD","IE00BLSP4239.USD","SGXZ57979304.SGD","LU1069347547.HKD","IE00BFXG1179.USD","ABBV","LU0203345920.USD","LU1585245621.USD","LU1718418525.SGD","BK4533","LU0648001328.SGD","LU1983299246.USD","SG9999002232.USD","LU1116320737.USD","BK4550","LU0965509010.AUD","LU0965509283.SGD","IE00B1BXHZ80.USD","LU0321505439.SGD","LU0306807586.USD","LU1868837300.USD","BK4559","LU0985481810.HKD","SNY","LU1941712348.USD","LU0234572021.USD","LU1061106388.HKD","LU0058720904.USD","LU0225771236.USD","IE00BBT3K403.USD","LU2106854487.HKD","LU1571399168.USD","BK4588","LU1934455194.USD","NVS","LU1868836757.USD","BK4007","LU0208291251.USD","LU0965509101.SGD","LU1023059063.AUD","BK4585","LU1699723380.USD","LU2023250504.SGD","LU1037948541.HKD","LU0006306889.USD","LU1057294990.SGD","MRK","LU1974910355.USD","LU2361044949.HKD","REGN","LU0265550359.USD","LU1066051498.USD","IE00B4R5TH58.HKD","SG9999001440.SGD","LU0456855351.SGD","IE0009355771.USD","LU1074936037.SGD","LU0477156953.USD","LU1093756168.USD","LU1323610961.USD","LU0070302665.USD","LU1261432733.SGD","LU1989771016.USD","BK4532","LU0320765646.SGD","LU0238689110.USD","BK4581","LU1989772840.SGD","LU2023250843.SGD","LU1066051811.HKD","LU1093756325.SGD","LU0106261372.USD","LU0061475181.USD","ROG","SG9999014559.SGD","AMGN","SG9999015358.SGD","LU0225284248.USD","LU0861579265.USD","IE00B2B36J28.USD","LU1934455277.USD","LU1670711040.USD","LU1941712264.USD","LU0130102774.USD","LU2324357040.USD","BK4534","LU0321505868.SGD","IE00BSNM7G36.USD","LU0211331839.USD","IE00BLSP4452.SGD","LU2461242641.AUD","LU0266013472.USD","LU1066051225.USD","LU0122379950.USD","LU2125154778.USD","LU1929549753.HKD","IE00BJJMRZ35.SGD","LU0267386448.USD","GILD","LU0306806265.USD","LU0098860793.USD","LU1035773651.USD","LU2089984988.USD","LU1201861249.SGD","LU1868836914.USD","LU1917777945.USD","LU1066053197.SGD","LU1291159041.SGD","LU2112291526.USD","IE0002141913.USD","LU2360032135.SGD","LU0096364046.USD","LU0265550946.USD","SG9999014575.USD","LU2242652126.USD","LU2361044865.SGD","LU1162221912.USD","SG9999001176.USD","LU0320765489.SGD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU1323610961.USD","IE00B2B36J28.USD","LU0122379950.USD","GILD","BK4585","LU1116320901.HKD","BIIB","LU2089984988.USD","LU0267386448.USD","SG9999014567.USD","LU2361045086.USD","LU1670711123.USD","SG9999002224.SGD","LU0823416689.USD","IE00BQJZX424.USD","IE00BSNM7G36.USD","SNY","LU1023059063.AUD","LU0114720955.EUR","SG9999014559.SGD","BK4534","LU1778281490.HKD","LU2023250504.SGD","LU0980610538.SGD","LU1974910355.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0203345920.USD","LU1868836757.USD","LU0266013472.USD","LU0289739699.SGD","LU2125154778.USD","LU0321505868.SGD","LU1098665638.USD","LU0234572021.USD","LU1670710661.SGD","SG9999001176.SGD","LU1057294990.SGD","LU1162221912.USD","LU1309081286.SGD","IE00B3T34201.USD","IE0002270589.USD","BK4599","LU0130517989.USD","LU1064927863.SGD","LU1868837300.USD","LU1839511570.USD","LU2324357040.USD","LU0225771236.USD","LU1571399168.USD","LU2361044865.SGD","SGXZ57979304.SGD","LU0225284248.USD","LU0106261372.USD","LU0109394709.USD","LU0234570918.USD","LU1228905540.USD","LU0965509101.SGD","LU1868837136.USD","SG9999015978.USD","LU1934455194.USD","LU0320765992.SGD","IE00BWDBJ516.SGD","BK4568","MRK","SG9999014575.USD","SG9999015945.SGD","IE00BLSP4239.USD","LU1116320737.USD","SG9999015341.SGD","LU0161305163.EUR","LU1037948897.HKD","LU1066051498.USD","LU1941712348.USD","LU0321505439.SGD","LU0237698245.USD","IE00BLSP4452.SGD","LU0477156953.USD","LU0985481810.HKD","IE00BKVL7J92.USD","LU2242646821.SGD","LU0265550359.USD","LU0965508806.USD","LU1941712264.USD","LU2133065610.SGD","LU0238689110.USD","BK4516","BK4581","LU0058720904.USD","LU0545562505.USD","LU1035777561.USD","SG9999015952.SGD","LU1202635105.USD","IE00B1BXHZ80.USD","LU0306806265.USD","LU0211331839.USD","LU2112291526.USD","LU0006306889.USD","LU2023250843.SGD","BK4139","NVS","LU0203347892.USD","LU1699723380.USD","LU0648001328.SGD","LU2468319806.SGD","LU0109981661.USD","LU1670710588.SGD","IE00B19Z3581.USD","LU1989771016.USD","IE0009355771.USD","LU1302929846.USD","IE000M9KFDE8.USD","LU1487256676.USD","IE0034235071.USD","LU1670756490.USD","BK4550","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1069347547.HKD","BK4578","BK4559","BK4532","IE00BJJMRZ35.SGD","LU1066051225.USD","LU1061106388.HKD","LU2087621335.USD","LU2361044949.HKD","RHHBY","GSK","LU0061475181.USD","LU2106854487.HKD","LU1917777945.USD","BK5011","LU1291159041.SGD","LU1989772840.SGD","LU1645745479.HKD","IE00BJT1NW94.SGD","LU0971552673.USD","LU1929549753.HKD","LU0320765646.SGD","LU1481600234.SGD","LU1718418525.SGD","LU2360032135.SGD","LU1670711040.USD","LU1046248800.SGD","LU0965509283.SGD","LU1015430645.USD","BK4588","LU2461242641.AUD","BK4566","LU1066053197.SGD","LU0130102774.USD","LU1983299246.USD","SG9999015358.SGD","LU1400636491.USD","IE0002141913.USD","LU0985320562.USD","LU1400636574.HKD","LU1400636657.SGD","LU1674673428.USD","LU0868494617.USD","IE00B19Z3B42.SGD","LU1093756325.SGD","LU1674673691.USD","04332","LU1201861249.SGD","LU0456855351.SGD","LU0965509010.AUD","LU1934455863.HKD","LU0208291251.USD","LU0861579265.USD","BK4583","SG9999014542.SGD","LU0882574055.USD","LU1481599808.USD","LU1868836591.USD","LU1228905037.USD","LU1585245621.USD","IE00BN8TJ469.HKD","LU1934455277.USD","LU1261432733.SGD","LU1066051811.HKD","LU1093756168.USD","IE00B7SZLL34.SGD","LU0971552830.HKD","IE00BFXG1179.USD","BK4533","LU1074936037.SGD","LU1868836914.USD","LU1035773651.USD","SG9999001176.USD","LU1037948541.HKD","LU0320765489.SGD","LU1430594728.SGD","BMY","BK4007","LU0070302665.USD","LU0098860793.USD","SG9999002232.USD","LU1032466523.USD","SG9999013999.USD","SG9999001440.SGD","LU2242652126.USD","IE00BBT3K403.USD","LU0265550946.USD","LU0575583348.USD","AMGN","LU0306807586.USD","LU2125154935.USD","SG9999015986.USD","LU0096364046.USD"],"gpt_icon":0},{"id":"1185501574","title":"公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员","url":"https://stock-news.laohu8.com/highlight/detail?id=1185501574","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185501574?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:21","pubTimestamp":1766172084,"startTime":"0","endTime":"0","summary":"公司将通过Trumprx网站以更低的价格向消费者直接提供多种药物-美国官员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1116320737.USD","IE00BLSP4452.SGD","LU0106261372.USD","BK4007","LU0098860793.USD","LU0225284248.USD","LU0965509283.SGD","LU1098665638.USD","BK4550","AMGN","GILD","LU0109981661.USD","LU1983299246.USD","LU1989771016.USD","LU1037948541.HKD","LU0823416689.USD","LU1400636491.USD","BMY","LU1585245621.USD","LU0320765489.SGD","LU0545562505.USD","IE00B19Z3581.USD","LU1302929846.USD","BK4578","GSK","LU1670756490.USD","LU1934455194.USD","LU1941712348.USD","IE00B1BXHZ80.USD","LU0265550359.USD","LU0575583348.USD","BK4534","LU1228905540.USD","LU0130517989.USD","LU0965508806.USD","LU1868837136.USD","IE00BLSP4239.USD","LU1037948897.HKD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU1069347547.HKD","LU0122379950.USD","LU1116320901.HKD","LU0237698245.USD","IE00B19Z3B42.SGD","LU1015430645.USD","LU1061106388.HKD","LU0058720904.USD","LU2023250843.SGD","IE00BJT1NW94.SGD","LU1941712264.USD","LU0965509010.AUD","LU2361044949.HKD","LU2361044865.SGD","LU1202635105.USD","LU2112291526.USD","IE0009355771.USD","BK4139","LU1718418525.SGD","LU2133065610.SGD","SG9999002232.USD","LU1645745479.HKD","LU0971552830.HKD","LU1323610961.USD","IE0002270589.USD","SG9999002224.SGD","SG9999015945.SGD","LU1674673691.USD","LU1064927863.SGD","LU1934455863.HKD","LU2242652126.USD","BK4585","LU2360032135.SGD","LU2324357040.USD","LU0267386448.USD","LU0006306889.USD","IE00BQJZX424.USD","LU1674673428.USD","BK4588","LU1839511570.USD","BK4559","LU1670710588.SGD","SG9999001176.USD","IE00BJJMRZ35.SGD","IE00BBT3K403.USD","LU0648001328.SGD","LU1571399168.USD","LU2461242641.AUD","IE00B2B36J28.USD","LU0971552673.USD","LU1162221912.USD","LU0203347892.USD","LU1868837300.USD","LU0882574055.USD","SG9999014542.SGD","LU0456855351.SGD","LU2125154935.USD","LU0861579265.USD","LU1261432733.SGD","LU0477156953.USD","LU0234572021.USD","SG9999014575.USD","LU0225771236.USD","SG9999015986.USD","LU0211331839.USD","LU1481599808.USD","LU1778281490.HKD","LU1046248800.SGD","LU0985481810.HKD","IE0034235071.USD","IE00B7SZLL34.SGD","LU0061475181.USD","LU0234570918.USD","IE00B3T34201.USD","LU1032466523.USD","LU2023250504.SGD","LU2087621335.USD","LU0266013472.USD","LU0320765992.SGD","LU0965509101.SGD","LU0161305163.EUR","SGXZ57979304.SGD","LU1309081286.SGD","IE00BFTCPJ56.SGD","LU0321505439.SGD","IE00BWDBJ516.SGD","SG9999001176.SGD","BK4533","LU0320765646.SGD","LU1035777561.USD","LU1699723380.USD","LU1917777945.USD","LU0306807586.USD","LU1989772923.USD","BK4568","LU1400636657.SGD","TRUMP","LU0203345920.USD","LU1670710661.SGD","SG9999014567.USD","LU2106854487.HKD","LU2468319806.SGD","LU0306806265.USD","LU1974910355.USD","LU1868836914.USD","LU2089984988.USD","LU2242646821.SGD","LU2361045086.USD","SG9999015341.SGD","LU0985320562.USD","BK4599","IE000M9KFDE8.USD","BK4532","IE00B4R5TH58.HKD","LU1487256676.USD","LU1057294990.SGD","LU1228905037.USD","BK4581","LU1670711040.USD","LU1989772840.SGD","SG9999015952.SGD","LU0109394709.USD","BK4566","LU0868494617.USD","MRK","LU0321505868.SGD","IE0002141913.USD","LU0114720955.EUR","LU0289739699.SGD","LU1074936037.SGD","LU1481600234.SGD","LU1670711123.USD","LU0265550946.USD","BK5011","LU1201861249.SGD","LU1929549753.HKD","LU1066051811.HKD","BK4516","LU1868836591.USD","LU1066051498.USD","SG9999015358.SGD","IE00BFXG1179.USD","SG9999015978.USD","LU0980610538.SGD","SG9999001440.SGD","LU1868836757.USD","LU0238689110.USD","LU0070302665.USD","LU1066051225.USD","LU1035773651.USD","LU1066053197.SGD","SG9999013999.USD","LU1291159041.SGD","IE00BSNM7G36.USD","IE00BN8TJ469.HKD","BK4583","LU1093756325.SGD","LU1400636574.HKD","SG9999014559.SGD","LU1023059063.AUD","LU2125154778.USD","LU1430594728.SGD","LU1934455277.USD","LU0096364046.USD","LU0208291251.USD","LU0130102774.USD","04332","LU1093756168.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"1119342602","title":"多家制造商同意向美国战略储备捐赠活性药物成分","url":"https://stock-news.laohu8.com/highlight/detail?id=1119342602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119342602?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:20","pubTimestamp":1766172037,"startTime":"0","endTime":"0","summary":"多家制造商同意向美国战略储备捐赠活性药物成分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU1074936037.SGD","LU0061475181.USD","LU0882574055.USD","LU1228905540.USD","LU1098665638.USD","LU2023250504.SGD","LU2087621335.USD","LU1974910355.USD","LU1868836914.USD","LU1057294990.SGD","LU1917777945.USD","BK4007","LU0234570918.USD","LU1032466523.USD","LU0265550359.USD","BK4550","LU1670710661.SGD","BK4533","LU1645745479.HKD","BK4559","BK4581","LU1202635105.USD","LU1868837136.USD","SG9999013999.USD","LU1487256676.USD","LU0122379950.USD","LU0971552673.USD","LU0456855351.SGD","LU0225771236.USD","LU1868837300.USD","BK4139","LU0234572021.USD","BK4578","LU0575583348.USD","LU1162221912.USD","IE000M9KFDE8.USD","LU1989772840.SGD","LU0965509101.SGD","BK4532","IE00B19Z3581.USD","LU1015430645.USD","LU2125154935.USD","LU0130517989.USD","LU2360032135.SGD","SG9999015952.SGD","BK4585","LU1699723380.USD","LU0868494617.USD","LU0267386448.USD","BK5011","LU0321505868.SGD","LU1037948541.HKD","LU1261432733.SGD","LU1670711123.USD","LU0971552830.HKD","LU1400636491.USD","LU1093756325.SGD","LU1066051498.USD","LU1481600234.SGD","IE00B1BXHZ80.USD","LU0225284248.USD","LU0861579265.USD","LU1061106388.HKD","SG9999015986.USD","LU0114720955.EUR","LU0070302665.USD","LU0889565916.HKD","LU2242652126.USD","LU2133065610.SGD","LU0237698245.USD","LU0985320562.USD","IE00BBT3K403.USD","BMY","LU1023059063.AUD","BK4599","IE00BSNM7G36.USD","LU0320765646.SGD","LU1839511570.USD","LU0096364046.USD","LU1571399168.USD","LU1064927863.SGD","LU0208291251.USD","LU0320765992.SGD","SG9999001176.USD","BK4588","BK4516","LU1228905037.USD","LU0985481810.HKD","LU2468319806.SGD","LU1046248800.SGD","IE0002141913.USD","LU1291159041.SGD","LU1066051225.USD","LU1066051811.HKD","LU2106854487.HKD","LU0203345920.USD","SG9999015978.USD","LU0109981661.USD","IE00BKVL7J92.USD","SG9999015945.SGD","GILD","LU0098860793.USD","SG9999015341.SGD","LU0006306889.USD","SGXZ57979304.SGD","04332","IE00B19Z3B42.SGD","LU1400636657.SGD","LU0266013472.USD","SG9999002224.SGD","LU1929549753.HKD","LU2089984988.USD","LU1035777561.USD","LU2361045086.USD","SG9999014575.USD","IE00BLSP4452.SGD","LU2023250843.SGD","SG9999015358.SGD","LU2242646821.SGD","LU1670710588.SGD","LU2461242641.AUD","LU1934455277.USD","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00BN8TJ469.HKD","GSK.UK","LU0965509283.SGD","LU1400636574.HKD","LU1983299246.USD","LU1116320901.HKD","LU0130102774.USD","SG9999014559.SGD","LU2361044865.SGD","IE00B3T34201.USD","LU1066053197.SGD","LU0306807586.USD","LU0648001328.SGD","LU2361044949.HKD","LU1674673691.USD","LU0058720904.USD","LU1201861249.SGD","LU1430594728.SGD","LU1868836757.USD","LU1323610961.USD","LU1585245621.USD","LU0265550946.USD","LU1670711040.USD","IE00B2B36J28.USD","LU0545562505.USD","SG9999014542.SGD","LU1718418525.SGD","IE00BWDBJ516.SGD","LU1116320737.USD","LU2112291526.USD","LU2125154778.USD","LU1989771016.USD","LU1037948897.HKD","LU1941712348.USD","LU1069347547.HKD","IE0002270589.USD","BK4583","LU0238689110.USD","LU0211331839.USD","LU1778281490.HKD","BK4568","IE00BLSP4239.USD","IE00BJJMRZ35.SGD","AMGN","BK4566","LU0477156953.USD","LU1309081286.SGD","LU0106261372.USD","LU1934455194.USD","LU2324357040.USD","LU1481599808.USD","LU1868836591.USD","LU0823416689.USD","IE00BQJZX424.USD","IE00BZ1G4Q59.USD","LU0980610538.SGD","IE00B4R5TH58.HKD","LU1093756168.USD","LU1941712264.USD","IE00B7SZLL34.SGD","LU0109394709.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU1989772923.USD","IE0009355771.USD","SG9999001176.SGD","IE0034235071.USD","LU0320765489.SGD","IE00BFXG1179.USD","BK4534","LU1035773651.USD","LU1302929846.USD","LU0965508806.USD","LU1674673428.USD","LU1670756490.USD","SG9999001440.SGD","SG9999002232.USD","LU0203347892.USD","LU1934455863.HKD","LU0306806265.USD","SG9999014567.USD","LU0161305163.EUR","MRK"],"gpt_icon":0},{"id":"2592902308","title":"III期ARTISTRY-2研究达主要终点,吉利德新型HIV二联疗法展现潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902308","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902308?lang=zh_cn&edition=full","pubTime":"2025-12-18 07:05","pubTimestamp":1766012717,"startTime":"0","endTime":"0","summary":"12月15日,吉利德宣布III期ARTISTRY-2研究取得积极顶线结果。吉利德计划将ARTISTRY研究的III期结果提交给监管机构,并将在未来的科学大会上公布详细数据。在ARTISTRY-2研究中,每日一次的单片复方方案BIC/LEN达到了主要成功标准,其疗效非劣于BIKTARVY。ARTISTRY-2的研究结果将与III期ARTISTRY-1研究的发现共同构成监管申报的基础。吉利德已于2025年11月公布了ARTISTRY-1的顶线结果,显示BIC/LEN组合耐受性良好,在疗效上非劣于多片式抗反转录病毒治疗方案。目前尚无治愈HIV或艾滋病的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218071039a6afa5d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218071039a6afa5d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1674673428.USD","SG9999015952.SGD","BK4550","IE00B7SZLL34.SGD","BK4583","III","LU0109394709.USD","LU1066053197.SGD","BK4588","IE0002270589.USD","LU0889565916.HKD","BK4578","LU0289739699.SGD","LU1839511570.USD","BK4139","IE00BZ1G4Q59.USD","LU2324357040.USD","IE00B19Z3581.USD","LU1066051498.USD","BK4134","IE00BKVL7J92.USD","LU1571399168.USD","LU0234570918.USD","IE00B3T34201.USD","LU0320765992.SGD","BK4568","SG9999015978.USD","BK4532","IE00B19Z3B42.SGD","LU0882574055.USD","BK4566","IE00BSNM7G36.USD","SG9999015986.USD","LU0114720955.EUR","BK4585","LU2087621335.USD","LU2468319806.SGD","LU0823416689.USD","LU2089984988.USD","LU1585245621.USD","LU1430594728.SGD","LU1674673691.USD","GILD","LU0058720904.USD","SG9999015945.SGD","LU1778281490.HKD"],"gpt_icon":0},{"id":"1132993871","title":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1132993871","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132993871?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:32","pubTimestamp":1765805534,"startTime":"0","endTime":"0","summary":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0114720955.EUR","SG9999015978.USD","BK4568","LU0320765992.SGD","LU0889565916.HKD","LU2089984988.USD","LU1674673428.USD","LU1066051498.USD","LU1430594728.SGD","LU2468319806.SGD","IE00B7SZLL34.SGD","BK4588","SG9999015952.SGD","LU1571399168.USD","GILD","LU2087621335.USD","LU0058720904.USD","IE0002270589.USD","IE00B19Z3581.USD","LU0289739699.SGD","BK4578","LU1839511570.USD","LU0882574055.USD","BK4583","LU1585245621.USD","SG9999015945.SGD","SG9999015986.USD","LU1066053197.SGD","LU1674673691.USD","LU1778281490.HKD","BK4566","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","LU0109394709.USD","BK4585","IE00B3T34201.USD","LU0234570918.USD","BK4139","IE00B19Z3B42.SGD","BK4550","LU2324357040.USD","LU0823416689.USD","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"1123601921","title":"吉利德科学 - 中期分析显示,Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123601921","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123601921?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:29","pubTimestamp":1765546157,"startTime":"0","endTime":"0","summary":"吉利德科学 - 中期分析显示,Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","BK4568","SG9999015945.SGD","BK4139","GILD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU1585245621.USD","IE0002270589.USD","LU1778281490.HKD","LU1430594728.SGD","IE00B7SZLL34.SGD","BK4566","BK4550","IE00B19Z3B42.SGD","LU1839511570.USD","LU2468319806.SGD","SG9999015986.USD","BK4585","LU1571399168.USD","BK4588","LU0058720904.USD","SG9999015952.SGD","LU1674673428.USD","LU2089984988.USD","BK4578","SG9999015978.USD","LU0889565916.HKD","LU1066051498.USD","IE00B3T34201.USD","LU0320765992.SGD","BK4532","LU0109394709.USD","LU0289739699.SGD","LU2324357040.USD","BK4583","LU1066053197.SGD","LU2087621335.USD","LU1674673691.USD","IE00BSNM7G36.USD","LU0234570918.USD","LU0114720955.EUR","IE00B19Z3581.USD","LU0882574055.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0371},{"period":"1month","weight":0.1751},{"period":"3month","weight":0.1617},{"period":"6month","weight":0.2957},{"period":"1year","weight":0.4701},{"period":"ytd","weight":0.1642}],"compareEarnings":[{"period":"1week","weight":0.0039},{"period":"1month","weight":0.0179},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.099},{"period":"1year","weight":0.1555},{"period":"ytd","weight":0.0198}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立,是一家以研究为基础的生物制药公司,致力于发现,开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病,炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.588235,"avgChangeRate":0.044916},{"month":2,"riseRate":0.428571,"avgChangeRate":0.007149},{"month":3,"riseRate":0.529412,"avgChangeRate":-0.009708},{"month":4,"riseRate":0.529412,"avgChangeRate":0.011973},{"month":5,"riseRate":0.558824,"avgChangeRate":0.0204},{"month":6,"riseRate":0.647059,"avgChangeRate":0.025673},{"month":7,"riseRate":0.558824,"avgChangeRate":0.01609},{"month":8,"riseRate":0.558824,"avgChangeRate":0.033158},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031157},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003173},{"month":11,"riseRate":0.647059,"avgChangeRate":0.039736},{"month":12,"riseRate":0.382353,"avgChangeRate":0.010114}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}